APA (7th ed.) Citation

Zhu, Z., Zhang, L., Elsherbini, A., Crivelli, S. M., Tripathi, P., Harper, C., . . . Bieberich, E. (2023). The S1P receptor 1 antagonist Ponesimod reduces TLR4-induced neuroinflammation and increases Aβ clearance in 5XFAD miceResearch in context. EBioMedicine, 94(104713-), . https://doi.org/10.1016/j.ebiom.2023.104713

Chicago Style (17th ed.) Citation

Zhu, Zhihui, Liping Zhang, Ahmed Elsherbini, Simone M. Crivelli, Priyanka Tripathi, Carmen Harper, Zainuddin Quadri, Stefka D. Spassieva, and Erhard Bieberich. "The S1P Receptor 1 Antagonist Ponesimod Reduces TLR4-induced Neuroinflammation and Increases Aβ Clearance in 5XFAD MiceResearch in Context." EBioMedicine 94, no. 104713- (2023). https://doi.org/10.1016/j.ebiom.2023.104713.

MLA (9th ed.) Citation

Zhu, Zhihui, et al. "The S1P Receptor 1 Antagonist Ponesimod Reduces TLR4-induced Neuroinflammation and Increases Aβ Clearance in 5XFAD MiceResearch in Context." EBioMedicine, vol. 94, no. 104713-, 2023, https://doi.org/10.1016/j.ebiom.2023.104713.